Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals submits press release

26 Jul 2025 Evaluate

Alembic Pharmaceuticals has submitted press release stating that Alembic Pharmaceuticals receives USFDA Final approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..